グリピカン3
関連文献

“Overgrowth syndromes and genomic imprinting: from mouse to man”. Clinical Genetics 53 (3):  165–70. (March 1998). doi:10.1111/j.1399-0004.1998.tb02668.x. PMID 9630066.
“Glypicans in growth control and cancer”. Glycobiology 11 (3):  19R–23R. (March 2001). doi:10.1093/glycob/11.3.19R. PMID 11320054.
“Identification of a new membrane-bound heparan sulphate proteoglycan”. The Biochemical Journal 311 ( Pt 2) (Pt 2):  561–5. (October 1995). doi:10.1042/bj3110561. PMC 1136036. PMID 7487896. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1136036/.
“K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney”. The Journal of Cell Biology 130 (5):  1207–18. (September 1995). doi:10.1083/jcb.130.5.1207. PMC 2120559. PMID 7657705. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2120559/.
“Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27”. Human Molecular Genetics 3 (1):  133–7. (January 1994). doi:10.1093/hmg/3.1.133. PMID 7909248.
“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene 138 (1–2):  171–4. (January 1994). doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
“Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization”. Mammalian Genome 8 (1):  72. (January 1997). doi:10.1007/s003359900357. PMID 9021160.
“Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5”. Gene 188 (2):  151–6. (April 1997). doi:10.1016/S0378-1119(96)00689-0. PMID 9133586.
“Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene”. Genomics 45 (1):  48–58. (October 1997). doi:10.1006/geno.1997.4916. PMID 9339360.
“Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution”. Cancer Research 57 (22):  5179–84. (November 1997). PMID 9371521.
“Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene 200 (1–2):  149–56. (October 1997). doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
“Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome”. Developmental Dynamics 213 (4):  431–9. (December 1998). doi:10.1002/(SICI)1097-0177(199812)213:4<431::AID-AJA8>3.0.CO;2-7. PMID 9853964.
“Glypican 3 and glypican 4 are juxtaposed in Xq26.1”. Gene 225 (1–2):  9–16. (December 1998). doi:10.1016/S0378-1119(98)00549-6. PMID 9931407. https://zenodo.org/record/1260055.
“A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family”. Journal of Medical Genetics 36 (1):  57–8. (January 1999). doi:10.1136/jmg.36.1.57. PMC 1762951. PMID 9950367. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762951/.
“Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene”. Human Molecular Genetics 9 (9):  1321–8. (May 2000). doi:10.1093/hmg/9.9.1321. PMID 10814714.
“Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast”. Histology and Histopathology 16 (1):  71–8. (January 2001). doi:10.14670/HH-16.71. PMID 11193214.